Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.
Toxicol Appl Pharmacol. 2010 Aug 15;247(1):60-9. doi: 10.1016/j.taap.2010.05.018. Epub 2010 Jun 4.
Flavin-containing monooxygenases often are thought not to be inducible but we recently demonstrated aryl hydrocarbon receptor (AHR)-dependent induction of FMO mRNAs in mouse liver by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Celius et al., Drug Metab Dispos 36:2499, 2008). We now evaluated FMO induction by other AHR ligands and xenobiotic chemicals in vivo and in mouse Hepa1c1c7 hepatoma cells (Hepa-1). In mouse liver, 3-methylcholanthrene (3MC) induced FMO3 mRNA 8-fold. In Hepa-1 cells, 3MC and benzo[a]pyrene (BaP) induced FMO3 mRNA >30-fold. Induction by 3MC and BaP was AHR dependent but, surprisingly, the potent AHR agonist, TCDD, did not induce FMO3 mRNA in Hepa-1 cells nor did chromatin immunoprecipitation assays detect recruitment of AHR or ARNT to Fmo3 regulatory elements after exposure to 3MC in liver or in Hepa-1 cells. However, in Hepa-1, 3MC and BaP (but not TCDD) caused recruitment of p53 protein to a p53 response element in the 5'-flanking region of the Fmo3 gene. We tested the possibility that FMO3 induction in Hepa-1 cells might be mediated by Nrf2/anti-oxidant response pathways, but agents known to activate Nrf2 or to induce oxidative stress did not affect FMO3 mRNA levels. The protein synthesis inhibitor, cycloheximide (which causes "superinduction" of CYP1A1 mRNA in TCDD-treated cells), by itself caused dramatic upregulation (>300-fold) of FMO3 mRNA in Hepa-1 suggesting that cycloheximide prevents synthesis of a labile protein that suppresses FMO3 expression. Although FMO3 mRNA is highly induced by 3MC or TCDD in mouse liver and in Hepa-1 cells, FMO protein levels and FMO catalytic function showed only modest elevation.
黄素单加氧酶通常被认为是不可诱导的,但我们最近证明,在小鼠肝脏中,2,3,7,8-四氯二苯并对二恶英(TCDD)(Celius 等人,《药物代谢与处置》36:2499,2008)通过芳香烃受体(AHR)依赖性诱导 FMO mRNAs。现在,我们评估了其他 AHR 配体和外源性化学物质在体内和小鼠 Hepa1c1c7 肝癌细胞(Hepa-1)中对 FMO 的诱导作用。在小鼠肝脏中,3-甲基胆蒽(3MC)诱导 FMO3 mRNA 增加 8 倍。在 Hepa-1 细胞中,3MC 和苯并[a]芘(BaP)诱导 FMO3 mRNA 增加 30 倍以上。3MC 和 BaP 的诱导作用依赖于 AHR,但令人惊讶的是,强效 AHR 激动剂 TCDD 并未在 Hepa-1 细胞中诱导 FMO3 mRNA,也未检测到 3MC 暴露后 AHR 或 ARNT 募集到 Fmo3 调节元件。然而,在 Hepa-1 中,3MC 和 BaP(但不是 TCDD)导致 p53 蛋白募集到 Fmo3 基因 5'-侧翼区的 p53 反应元件。我们测试了 Hepa-1 细胞中 FMO3 诱导可能由 Nrf2/抗氧化反应途径介导的可能性,但已知激活 Nrf2 或诱导氧化应激的药物不会影响 FMO3 mRNA 水平。蛋白合成抑制剂环己酰亚胺(在 TCDD 处理的细胞中引起 CYP1A1 mRNA 的“超级诱导”)本身导致 Hepa-1 中 FMO3 mRNA 的急剧上调(>300 倍),表明环己酰亚胺阻止了抑制 FMO3 表达的不稳定蛋白的合成。尽管 3MC 或 TCDD 在小鼠肝脏和 Hepa-1 细胞中高度诱导 FMO3 mRNA,但 FMO 蛋白水平和 FMO 催化功能仅显示适度升高。